Medindia LOGIN REGISTER
Medindia
Advertisement

FDA Starts Review of Biogenís Therapy for Hemophilia B

by Kathy Jones on March 5, 2013 at 9:06 PM
 FDA Starts Review of Biogenís Therapy for Hemophilia B

The US Food and Drug Administration is currently reviewing Biogen Idec's application for a fusion protein therapy designed to treat hemophilia B, the company said.

The company revealed that its drug, rFIXFc, has been designed to last longer than currently available drugs and allows patients to endure fewer treatments.

Advertisement

The FDA will be conducting a 10-month review of the drug and is expected to reach a decision in January next year.

Source: Medindia
Font : A-A+

Advertisement

Advertisement
Advertisement

Recommended Readings

Latest Drug News

Can a Needle-Free Patch Transform Zika Protection?
Researchers create needle-free Zika vaccine patch, using HD-MAP tech, aiming to protect against fatal virus spread by mosquitoes.
Prolonging Market Exclusivity of Brand-name Insulin
Examining FDA and patent records, researchers found that insulin manufacturers prolong market exclusivity for brand-name products.
FDA Boosts Orphan Drug Designations for Myelofibrosis Treatments
The rise in FDA ODD awards indicates a collective endeavor to create new myelofibrosis medications devoid of mechanisms inducing anemia.
Anti-Rheumatic Drugs May Help Prevent Thyroid Disease
The most significant decrease in autoimmune thyroid disease risk was observed in rheumatoid arthritis patients receiving immunomodulatory drugs or 'biological DMARDs'.
Apotransferrin's Potential in Early Stroke Therapy Revealed
Human apotransferrin injected to mice models suffering from intracerebral hemorrhage was found to mitigate the serious effects of stroke.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close
×

FDA Starts Review of Biogenís Therapy for Hemophilia B Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests